Keywords: polish, pharma, market, set, recovery, poland, pharmaceuticals
Polish pharma market set for recovery
Article | 21 March 2005
Poland's pharmaceuticals market is set to increase in value about 5%-10% this year, reaching an estimated 17.5 billion zlotys ($5.90 billion), according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
